Potential for preventive effects of cocoa and cocoa polyphenols in cancer by Martín, M. Ángeles et al.
1 
 
Potential for preventive effects of cocoa and cocoa 
polyphenols in cancer 
 
Maria Angeles Martin, Luis Goya and Sonia Ramos* 
 
Department of Metabolism and Nutrition 
Institute of Food Science and Technology and Nutrition (ICTAN-CSIC) 
José Antonio Novais 10 
Ciudad Universitaria, 28040, Madrid 
Spain 
Phone: +34.91.544.56.07 
Fax: +34.91.549.36.27 
 
* Corresponding author: e-mail: s.ramos@ictan.csic.es 
1
 
                                                 
1 Abbreviations: AhR, aryl hydrocarbon receptor; AKT/PKB, protein kinase B; AOM, 
azoxymethane; AP, Acticoa power; AP-1, activator protein-1; ARE, antioxidant response 
element; CDK, cyclins-dpendent kinase; CLPr, cacao liquor proanthocyanidins; COX-2, 
cyclooxygenase-2; CYP, cytochrome P450; DEN, diethylnitrosamine; EC, (-)-epicatechin; 
DMBDD, 2,2’-dihydroxy-di-n-propylnitrosamine; DOC, deoxycholic; ERK, extracellular 
regulated kinase; DMBA, dimethylbenz[a]anthracene; FAK, focal adhesion kinase; GPx, 
glutathione peroxidase; GR, glutathione reductase; GSH, glutathione; GST, glutathione-S-
tranferases; IκB, inhibitor of κB; HUVEC, human endothelial cell; IL, interleukin; iNOS, 
inducible nitric oxide synthase; JNK, c-Jun N-terminal kinase; Keap1, Kelch-like ECH-
associating protein-1; LPS, lipopolysaccharide; MAPKs, mitogen-activated protein kinase; 
MEK, mitogen activated protein kinase kinase; MNU, N-methylnitrosourea; NF-κB, nuclear 
factor kappa B; Nrf2, nuclear-factor-E2-related factor 2; 8-oxodG, 8-oxo-7,8-dihydro-2´-
deoxyguanosine; PhIP, 1-methyl-6-phenylimidazo [4,5-b]-pyridine; PI3K, PI-3-kinase, 
phosphatidylinositol-3-kinase; PKC, protein kinase C; PMA, phorbol 12-myristate 13-acetate; 
PB2, procyanidin B2; ROS, reactive oxygen species; SOD, superoxide dismutase; t-BOOH, 
tert-butylhydroperoxide; TPA, 12-O-tetradecanoylphorbol 13-acetate; TNFα, tumour necrosis 
factor α; Topo , topoisomerase; VEGF, vascular endothelial growth factor. 
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Abstract 
Prevention of cancer through the diet is receiving increasing interest, and cocoa because of its 
polyphenolic compounds has become an important potential chemopreventive and therapeutic 
natural agent. Cocoa and its main polyphenols have been reported to interfere at the initiation, 
promotion and progression of cancer. Cocoa flavonoids have been demonstrated to influence 
several important biological functions in vitro and in vivo by their free radical scavenging 
ability or through the regulation of signal transduction pathways to stimulate apoptosis and to 
inhibit inflammation, cellular proliferation, apoptosis, angiogenesis and metastasis. 
Nevertheless, these molecular mechanisms of action are not completely characterized and many 
features remain to be elucidated. The aim of this review is to provide insights into the molecular 
basis of the potential chemopreventive activity of cocoa and its polyphenolic components by 
summarizing cell culture and animal models studies, as well as interventional and 
epidemiological studies on humans. 
 
Keywords: Cocoa, cancer, inflammation, antioxidant defenses, cell death, survival/proliferation 
pathways. 
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Highlights 
- Cocoa promotes changes in redox-sensitive signaling pathways involved in the expression of 
many genes and cell functions. 
- Cocoa may prevent chronic inflammatory response and oxidative damage and thus affect 
carcinogenesis. 
- Cocoa has been demonstrated to increase serum antioxidant status and apoptosis of cancer 
cells, theoretically reducing cancer risk. 
- Research to date suggests that moderate cocoa or dark chocolate consumption may reduce 
cancer risks. 
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1.- Introduction 
Carcinogenesis is generally a slow process and often takes decades from tumor initiation to 
diagnosis, offering a considerable time frame for chemopreventive approaches. 
Chemoprevention is defined as the use of specific natural (dietary) or synthetic agents to 
prevent, delay, or slow the carcinogenic process (Kelloff et al., 2006). Accumulating 
epidemiological and experimental studies suggest that a high consumption of fruits and 
vegetables and the intake of certain non-nutrients that are present in foods reduce the risk of 
different cancers (Ramos, 2008, Surh, 2003). Therefore, the identification of dietary 
components as potential cancer chemopreventive agents in the form of functional foods or 
nutraceuticals has become an essential subject for study in current research. This is the case for 
polyphenols, natural dietary compounds present in fruits and vegetables, which have attracted a 
great deal of interest because of their potential ability to act as highly effective 
chemopreventive agents (Ramos, 2008). In addition, the low toxicity and the very few adverse 
side effects linked to polyphenols consumption give them potential advantages.  
Cocoa, the dried and fermented seeds derived from Theobroma cacao, has been consumed 
since 1100 B.C. by ancient civilizations such as the Mayans and Aztecs (Hurst et al., 2002). In 
the 16th century cocoa was introduced into Europe by Hernan Cortes and, three centuries later, 
Conrad van Houten developed cocoa powder as we know it today (Dillinger et al., 2000, 
Rössner, 1997). Cocoa powder is a rich source of fiber (26–40 %), proteins (15–20 %), 
carbohydrates (about 15 %) and lipids (10–24%) and it contains minerals and vitamins 
(Ramiro-Puig and Castell, 2009). Out of more than 200 compounds found in the cocoa bean 
that are thought to be beneficial for the human body, research is mainly focused on 
polyphenols, particularly the flavanols, that are so abundant in this ancient plant (Visioli et al., 
2009). Cocoa has the highest flavanol content of all foods on a weight basis and is a significant 
contributor to the total dietary intake of flavonoids (Lee et al., 2003, Rusconi and Conti, 2010, 
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Vinson et al., 1999). Principally, cocoa contains high amounts of flavonoids (-)-epicatechin 
(EC), (+)-catechin and their dimers procyanidins B2 (PB2) and B1, although other polyphenols 
such as quercetin, isoquercitrin (quercetin 3-O-glucoside), quercetin 3-O-arabinose, hyperoside 
(quercetin 3-O-galactoside), naringenin, luteolin and apigenin have also been found in minor 
quantities (Sánchez-Rabaneda et al., 2003). 
Cocoa is a rich source of antioxidants; in a study that measured the total concentration of redox 
compounds in 1,113 different foods, of the 50 foods with the highest antioxidant capacity, 5 
were cocoa based (Halvorsen et al., 2006). Besides, cocoa and derivatives are widely consumed 
worldwide due to the highly attractive organoleptic characteristics. Indeed, cocoa products 
constitute a larger proportion of the diet of many individuals than green tea, wine, or soy beans 
(Arts et al., 2001, Tabernero et al., 2006). The mean intake of catechins and procyanidins 
estimated for USA is higher than the estimated intake of other flavonoids (Gu et al., 2004). 
Chocolate consumption contributed 2 to 5 mg of daily catechin intake out of an estimated total 
of 50 mg per day in a report from the Netherlands (Arts et al., 2001). For the Spanish diet, it 
was estimated that cocoa products account for 10% of the total antioxidant capacity of dietary 
intake (Tabernero et al., 2006). 
Health effects derived from cocoa flavonoids depend on their bioavailability (absorption, 
distribution, metabolism, and elimination), a factor which is also influenced by their chemical 
structure (Manach et al., 2005). In this regard, different studies have shown the absorption of 
catechin, EC and dimeric procyanidins after the intake of different cocoa by-products by 
animals and humans (Lamuela-Raventós et al., 2005, Urpi-Sarda et al., 2009). In particular, 
monomeric flavonoids are absorbed in the small intestine and they and their metabolites (eg, 
methylated, sulfated, and glucuronidated compounds), which could also be bioactive, are 
rapidly detected in plasma at concentrations in the range of nM to μM (Baba et al., 2000, Holt 
et al., 2002, Roura et al., 2005, Uhlenhut and Högger, 2012) and urine (Tsang et al., 2005). 
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Accordingly, absorbed flavonoids are widely distributed and can be detected in lymphoid 
organs, including the thymus, spleen and mesenteric lymphoid nodes, as well as in the liver and 
testes at different concentrations (Urpi-Sarda et al., 2010). In contrast, procyanidins (dimers and 
trimers) and large proanthocyanidins appear to be 10- to 100-fold less absorbed (Manach et al., 
2005, Serra et al., 2010); therefore, their beneficial effects could be restricted to the 
gastrointestinal tract where they may have an important local function (Ramiro-Puig and 
Castell, 2009). In addition, oligomers and polymers of flavanols that are not absorbed through 
the gut barrier could be metabolized by the intestinal microbiota into various phenolic acids of 
low molecular weight, which are more bioavailable, and might be well absorbed through the 
colon (Urpi-Sarda et al., 2009, Urpi-Sarda et al., 2010). Interestingly, recent findings have 
demonstrated that some of these microbial metabolites derived from cocoa consumption also 
possess biological properties (Monagas et al., 2010). 
The present review will focus on the molecular basis of the potential chemopreventive activity 
of cocoa and their polyphenolic components. Firstly, this paper summarizes recent in vitro 
studies which have evaluated the potential anti-carcinogenic properties of cocoa and their 
components and the molecular mechanism involved. Although in vitro studies will provide a 
hint to potential cancer preventive effects in vivo, chemopreventive efficacy of natural products 
can only be demonstrated in animal models or human intervention studies. Therefore, in the 
second part, investigations on the effect of cocoa in various animal models of carcinogenesis 
are also presented. Finally, this review briefly describes the current evidence on the link 
between cocoa and cancer occurrence, based on interventional and epidemiological studies on 
humans. 
 
2.- Studies in cell culture 
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Cell culture studies constitute a useful tool to elucidate the molecular mechanisms of action 
of cocoa extracts and its polyphenolic compounds in different cancer cell lines. In this regard, 
it should be mentioned that pure compounds are metabolized and circulate in the plasma, 
although the free aglycone is accumulated in tissues as a consequence of a conjugation-
deconjugation cycle; thus, pure phenolic compounds seem not to be bioactive unless 
deconjugation occur in the cell, being the free aglycone the final effector, as already reported 
for quercetin (Perez-Vizcaino et al., 2012). Moreover, intracellular and bound phenolic 
metabolite concentrations can be higher than plasma levels and be bioactive even when 
plasma concentrations are in the nM range (Uhlenhut and Högger, 2012). 
 
2.1- Antioxidant and detoxifying effects 
Cells are continuously threatened by the damage caused by free radicals and reactive oxygen 
species (ROS), which are produced during normal oxygen metabolism or induced by exogenous 
damage (Finkel and Holbrook, 2000). In physiological conditions, there is a balance between 
ROS generation and neutralization, and to this equilibrium contribute the antioxidant-defense 
mechanisms of the body, which include enzymes such as catalase, superoxide dismutase (SOD) 
and glutathione peroxidase (GPx) and non-enzymatic defenses (glutathione, acid ascorbic, etc.) 
(Finkel and Holbrook, 2000). In pathological situations, this balance can be altered and an 
accumulation of free radicals at the early stages and in the progression of cancer might lead to 
an oxidative cellular damage or to an alteration in a signaling pathways since ROS may act as 
signaling molecules (Finkel and Holbrook, 2000). Thus, foods containing antioxidants such as 
vegetables, fruits, soy products, cocoa and tea that counteract ROS are expected to be protective 
in cancer causation and development. 
Flavonoids can prevent the DNA-damage caused by free radicals or carcinogenic agents acting 
through different ways: (i) direct radical scavenging, (ii) chelating divalent cations involved in 
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the Fenton reaction (Nakagawa et al., 2004), (iii) modulation of enzymes related to oxidative 
stress (GPx, SOD, nitric-oxide synthase, lipooxygenase, xanthine oxidase, etc.) and (iv) 
alteration of procarcinogenic metabolism by inhibiting phase-I drug-metabolizing enzymes 
(cytochrome P450, CYP) or activating phase II conjugating-enzymes (glucuronidation, 
sulfation, acetylation, methylation and conjugation). 
2.1.1.- Protective effects against oxidative stress 
Cocoa has a potent antioxidant capacity as compared with other products, and this property has 
been related to its flavonoid content (Lee et al., 2003). Thus, a cocoa extract and its main 
flavonoid, EC, exerted a similar neuroprotective effect by diminishing intracellular ROS 
production in H2O2/Fe
2+
-stimulated SH-SY5Y cells (Ramiro-Puig et al., 2009) (Table 1). In this 
line, a cocoa phenolic extract and PB2 counteracted acrylamide-induced cytotoxicity by 
inhibiting glutathione (GSH) consumption and ROS generation, and increasing the levels of 
gamma-glutamyl cysteine synthase and glutathione-S-transferase (GST) in Caco-2 cells 
(Rodriguez-Ramiro et al., 2011b). Similarly, a cocoa phenolic extract and EC induced 
beneficial changes in the antioxidant defense system in a human hepatic cell line (HepG2) 
(Granado-Serrano et al., 2007, Martín et al., 2008, Martín et al., 2010b); both substances 
prevented or delayed conditions which favored cellular oxidative stress. In particular, the cocoa 
polyphenolic extract increased the activity of GPx and glutathione reductase (GR) via 
extracellular regulated kinase (ERK) activation (Martín et al., 2010a), and the pretreatment of 
cells with the cocoa polyphenolic extract completely prevented cell damage and enhanced 
activity of the antioxidant enzymes GPx and GR induced by the pro-oxidant tert-
butylhydroperoxide (t-BOOH). Moreover, depletion of GSH and ROS over-production caused 
by t-BOOH in HepG2 cells were prevented by the pretreatment with the cocoa polyphenolic 
extract (Martín et al., 2008). Accordingly, EC is also a powerful radical scavenger. EC reduced 
the cytotoxicity induced by t-BOOH (Granado-Serrano et al., 2009, Martín et al., 2010b) and 
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conferred a protection against oxidative stress by preventing t-BOOH-induced increase of ROS, 
malondialdehyde, GPx and GR activities as well as the decrease of GSH in HepG2 cells 
(Martín et al., 2010b, Murakami et al., 2002). EC also protected cells from oxidative insults by 
preventing hydroxyl radical formation in the presence of copper (Azam et al., 2004), and played 
a role in modulating oxidative stress in lead-exposed cells through the downregulation of ROS 
generation, decrease of intracellular calcium and prevented the alteration of the mitochondrial 
membrane potential (Chen et al., 2002, Chen et al., 2003). Moreover, EC and one its major 
metabolites in vivo, 3´-O-methyl epicatechin, protected human fibroblasts against oxidative 
stress induced by H2O2 (Spencer et al., 2001b) and UVA light (Basu-Modak et al., 2003). 
Cocoa and its main flavanols prevent the oxidative damage to DNA. In calf thymus DNA, 
procyanidins isolated from cocoa, EC and (+)-catechin inhibited 8-oxo-7,8-dihydro-2´-
deoxyguanosine (8-oxodG) production in a concentration- and time-dependent manner. EC was 
more efficient than catechin with respect to inhibiting 8-oxodG formation, although monomer, 
tetramer, and hexamer fractions were equally effective in inhibiting 8-oxodG formation when 
assayed at 10 µM monomer equivalent concentration, suggesting that both epimerism and 
degree of oligomerization are important determinants for the antioxidant activity of flavan-3-ols 
and procyanidins (Ottaviani et al., 2002). EC and (+) catechin also protected HepG2 cells 
against oxidative DNA damage induced by N-nitrosamines and heterocyclic amines as reduced 
DNA strand breaks, the formation of endonuclease III and oxidized purines and pyrimidines 
(Delgado et al., 2009, Haza and Morales, 2011). 
2.1.2.- Molecular mechanisms related to the cellular protective effect 
One possible mechanism by which cocoa and its phenolic compounds might exert their 
protective effect towards oxidative stress-induced damage may be through the modulation of 
phase I and II enzyme activities. A polyphenolic cocoa extract increased CYP1A1 mRNA and 
protein levels and enzymatic activity in MCF-7 and SKBR3 breast cancer cells (Oleaga et al., 
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2012). In particular, the CYP1A1 transcriptional activation by the polyphenolic cocoa extract 
was mediated through aryl hydrocarbon receptor (AhR) binding to xenobiotic response 
elements within the CYP1A1 promoter in MCF-7 cells. Additionally, CYP1A1 overexpression 
might interfere with estrogen metabolism and the production of estrogen metabolites in breast 
cells, which suggest that the interaction between estrogen receptor α and AhR upon incubation 
with the polyphenolic cocoa extract lead to CYP1A1 induction in breast cancer cells (Oleaga et 
al., 2012). In this regard, (+)-catechin moderately inhibited CYP1A1 activity induced by 
heterocyclic amines, whereas EC showed a weaker effect on the inhibition of the activity of 
CYP1A1 in HepG2 cells (Haza and Morales, 2011). However, (+)-catechin induced the greatest 
increase in the activity of the phase II metabolizing enzyme UDP-glucuronyltransferase  (Haza 
and Morales, 2011). Similarly, EC increased NADPH cytochrome c reductase activity in MCF-
7 breast cancer cells (Rodgers and Grant, 1998). 
PB2 dimer and to a lesser extent EC and related metabolites [3′-O-methyl epicatechin, 4′-O-
methyl epicatechin, and (−)-epicatechin glucuronide] inhibited the activity of NADPH-oxidase 
in cultures of human umbilical vein endothelial cells (Steffen et al., 2008, Steffen et al., 2007). 
Interestingly, flavanols and procyanidins of cocoa were able to alter the cellular oxidant 
production as a result of inhibiting the binding of a ligand to its receptor. This is the case for 
tumor necrosis factor (TNF)-α, whose binding to TNFα receptor 1 leads to the activation of 
NADPH-oxidase and to the subsequent superoxide anion production (Yang and Rizzo, 2007). 
In intestinal cells, EC, (+)-catechin, B2 dimers, and hexameric procyanidins decreased the 
transient increase in oxidants associated with TNFα-triggered signaling (Erlejman et al., 2008). 
Upregulation of cytoprotective enzymes by therapeutic agents to prevent damage by ROS and 
xenobiotic electrophiles is a strategy for cancer chemoprevention. The Kelch-like ECH-
associated protein 1 (Keap1) and its binding partner, transcription factor NF-E2-related factor-2 
(Nrf2), are chemopreventive targets because of their role in regulating the antioxidant response 
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element (ARE), which is present in the promoter region of many antioxidant genes, in response 
to oxidative stress and exposure to electrophiles. Modification of the sensor protein Keap1 by 
electrophiles such as the cocoa and its phenolic compounds can direct Nrf2 accumulation in the 
nucleus and subsequent ARE activation. In this regard, it has been described that EC induces 
Nrf2 translocation and phosphorylation via ROS generation, through the modulation of 
proliferation/survival pathways in human HepG2 cells (Granado-Serrano et al., 2010). EC also 
increased GSH content and stimulated Nrf2 via AKT (protein kinase B) in astrocytes (Bahia et 
al., 2008). Accordingly, catechin decreased lipid peroxidation and ROS, and increased the 
activity of GPx, GR total sulfhydryl groups and the expression of Nrf2 and heme oxygenase-1 
in intestinal Int-407 cells (Cheng et al., 2012). PB2 also evoked a dose-dependent increase in 
GPx, GR and GST, which could be related to an improved cell response to an oxidative 
challenge (Rodriguez-Ramiro et al., 2011a). Hence, Caco2 cells treated with PB2, and then 
submitted to an oxidative stress induced by t-BOOH showed a reduced ROS production, 
restricted activation of caspase 3 and higher viability than cells only submitted to the stressor 
(Rodriguez-Ramiro et al., 2011a). PB2 also showed a protective effect against the oxidative 
injury induced by t-BOOH in colonic cells through the upregulation of the expression of 
GSTP1 via a mechanism that involved ERK and p38 mitogen-activated protein kinase (MAPK) 
activation and Nrf2 translocation (Rodrıguez-Ramiro et al., 2011). 
Procyanidin dimers and trimers isolated from cocoa can provide protection against the attack of 
oxidants and other molecules that challenge the integrity of the bilayer by interacting with 
membrane phospholipids, presumably with their polar headgroup (Verstraeten et al., 2005). 
Similarly, a hexameric procyanidin fraction isolated from cocoa interacted with Caco-2 cell 
membranes preferentially at the water–lipid interface without affecting their integrity, and it 
inhibited the deoxycholic (DOC)-induced cytotoxicity, oxidant generation, NADPH oxidase 
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activation, loss of monolayer integrity and DOC-triggered increase in cellular calcium (Da 
Silva et al., 2012, Erlejman et al., 2006). 
2.1.3.- Pro-oxidative effect 
Despite these well-defined antioxidant characteristics, flavonoids can become pro-oxidants 
under certain conditions, such as high flavonoid concentrations and the presence of redox-
active metals (Sakano et al., 2005). PB2 inhibited the formation of 8-oxodG in the human 
leukemia cell line HL-60 treated with an H2O2-generating system. In contrast, a high 
concentration of PB2 increased the formation of 8-oxodG in HL-60 cells (Sakano et al., 2005). 
Experiments with calf thymus DNA also revealed that PB2 decreased 8-oxodG formation by 
Fe(II)/H2O2, whereas PB2 induced DNA damage in the presence of Cu(II), and H2O2 
extensively enhanced it. This suggests that PB2 exerts both antioxidant and pro-oxidant 
properties by interacting with H2O2 and metal ions (Sakano et al., 2005). 
 
2.2- Anti-inflammatory effects 
The association between inflammation and cancer involves key inflammatory mediators such as 
nuclear factor kappa B (NF-ĸB), TNFα, cyclooxygenase-2 (COX-2), etc. These proteins are 
also related to cell proliferation, anti-apoptotic activity, angiogenesis and metastasis (Table 2) 
(Ramos, 2008). 
Cocoa phenolic extract inhibited the inflammatory mediator prostaglandin E2 in human 
intestinal Caco-2 cells (Romier-Crouzet et al., 2009). Similarly, a cocoa polyphenolic extract 
dose-dependently diminished the secretion of monocyte chemoattractant protein 1 and TNFα, 
this effect being greater than that produced by equivalent concentrations of EC (Ramiro et al., 
2005). Interestingly, cocoa extract added prior to monocyte activation with lipopolysaccharide 
(LPS) resulted in a significantly greater inhibition of TNFα secretion. Both cocoa extract and 
EC decreased TNFα, interleukin (IL) 1α and IL-6 mRNA expression, and cocoa phenolic 
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extract also diminished NO secretion in a dose-dependent manner and with a greater effect than 
that produced by EC (Ramiro et al., 2005). Accordingly, two cocoa extracts inhibited phorbol 
12-myristate 13-acetate (PMA)- induced superoxide production, IL-1 and IL-6 release in human 
monocytes (Zeng et al., 2011), and cocoa polyphenols also dose-dependently inhibited xanthine 
oxidase activity and 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced superoxide-anion 
generation in cultured human promyeolcytic leukemia HL-60 cells (Lee et al., 2006). In mouse 
epidermal cells, cocoa polyphenols inhibited TNFα-induced phosphorylation of AKT and ERK, 
as well as the activation of downstream kinases (p70 kDa ribosomal protein S6 kinase and p90 
kDa ribosomal protein S6 kinase) and suppressed the TNFα-induced MEK1 (mitogen activated 
protein kinase kinase-1) activity and the phosphatidylinositol-3-kinase (PI3K) activity via 
binding PI3K directly, suggesting a chemopreventive potential against pro-inflammatory 
cytokine-mediated skin cancer and inflammation (Kim et al., 2010). Correspondingly, (+)-
catechin and EC inhibited nitrite and TNFα production in LPS-stimulated macrophages and 
murine aorta endothelial cells, respectively (Guruvayoorappan and Kuttan, 2008, Schroeder et 
al., 2001). More recently, a cocoa phenolic extract significantly reduced the increase in 
inflammatory markers such as IL-8 secretion, COX-2 and inducible nitric oxide synthase 
(iNOS) expression induced by the pro-inflammatory agent TNFα in Caco-2 cells (Rodrıiguez-
Ramiro et al., 2012). In this study, cocoa phenolic extract selectively decreased both the 
phosphorylation of c-Jun N-terminal kinase (JNK) and the nuclear translocation of NK-κB 
induced by TNFα, indicating that this pathway could be an important mechanism contributing 
to the reduction of intestinal inflammation. 
EC and procyanidins can inhibit NF-κB at different levels in the activation pathway. A decrease 
in cell oxidants that are involved in NF-κB activation is a potential mechanism of modulation 
by these compounds. Thus, hexameric procyanidins inhibited TNFα-induced NF-ĸB activation 
[inhibitor of κB (IĸB) phosphorylation and degradation, p50 and RelA nuclear translocation, 
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and NF-ĸB–DNA binding], iNOS, and cell oxidant increase in Caco-2 cells (Erlejman et al., 
2008). These effects occurred because hexameric procyanidins can inhibit NF-ĸB activation by 
interacting with the plasma membrane of intestinal cells, and through these interactions 
preferentially inhibit the binding of TNFα to its receptor and the subsequent NF-ĸB activation 
(Erlejman et al., 2008). PB2 also inhibited the binding of NF-κB proteins, i.e., RelA and p50, to 
its κB DNA consensus sequence in whole cells, nuclear fractions, and purified chemical 
systems (Mackenzie et al., 2008, Mackenzie et al., 2004, Mackenzie et al., 2009). Thus, 
procyanidins B1 and B2 inhibited TNFα and PMA-induced transactivation of NF-ĸB and NF-
ĸB–DNA nuclear binding in Jurkat T cells, whereas none of these effects were observed with 
A1 and A2 procyanidins, suggesting that B-type dimeric procyanidins can provide anti-
inflammatory benefits due to their ability to reduce NF-ĸB binding to the DNA (Mackenzie et 
al., 2009). To a lesser degree, EC can also interact with NF-κB and inhibit TNFα-stimulated 
and constitutive NF-κB activation in T lymphocytes (Jurkat) and Hodgkin lymphoma cells, 
respectively (Mackenzie et al., 2004, Mackenzie and Oteiza, 2006). However, in HepG2 cells, 
EC transiently stimulated the NF-ĸB pathway: increased NF-ĸB(p65) levels and IκB kinase, 
induced NF-ĸB nuclear translocation and NF-ĸB-binding activity, as well as IĸB 
phosphorylation and degradation (Granado-Serrano et al., 2010). The induction of the redox-
sensitive transcription factor NF-ĸB was connected to ERK, which is involved in the control of 
hepatic cell survival and proliferation, pointing out to the role of EC in the promotion of cell 
protection and survival pathways (Granado-Serrano et al., 2010). 
 
2.3.- Effects on apoptosis and proliferation 
In chemoprevention, suppression of cell proliferation and induction of differentiation and 
apoptosis are important strategies, with the induction of programmed cell death currently 
considered as one relevant target in a preventive approach. 
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2.3.1.- Cell cycle 
Deregulated cell cycle and resistance to apoptosis are hallmarks of cancer (Ramos, 2008). Cell 
cycle control is a highly regulated process that involves the modulation of cell cycle regulatory 
proteins, including cyclins (cyclin A, B, D, or E), cyclin-dependent kinases (CDKs) (CDK 1, 2, 
4, or 6), and CDK inhibitors, such as p21, p27, p53, and phosphorylated retinoblastoma (pRb) 
(Ramos, 2008). Any alteration of cell cycle-specific proteins can affect and/or block the 
continuous proliferation of cancer cells. In addition, cell cycle checkpoints, such as G1/S and 
G2/M, are also important targets for cocoa and its polyphenols (Table 3). 
Type II topoisomerases (topo II) are enzymes that transiently modify the DNA topology to 
allow DNA replication, transcription and chromosomal recombination and segregation. Thus, 
inhibition of topoisomerases leads to cellular accumulation of DNA strand breaks and can result 
in cell death, which is the desired effect of anti-cancer drugs (Lanoue et al., 2009). Limited topo 
II inhibition and low cellular toxicity were observed for a procyanidin-rich cocoa extract in 
leukemia cells (Lanoue et al., 2009). The dimers (B2, B5 and a mix of both) were the most 
active inhibitors of topo II and proliferation in HL-60 and Raji cells lines (Lanoue et al., 2009). 
Cocoa-derived pentameric procyanidin (pentamer) caused G0/G1 cell cycle arrest in human 
breast cancer  MDA MB-231, MDA MB-436, MDA MB-468, SKBR-3, and MCF-7 cells and 
in benzo(a)pyrene-immortalized 184A1N4 and 184B5 cells, whereas normal human mammary 
epithelial cells in primary culture and spontaneously immortalized MCF-10A cells were 
resistant (Ramljak et al., 2005). Pentamer caused depolarization of mitochondrial membrane in 
MDA MB231 cells but not in MCF-10A cells. In addition, in MDA MB-231 cells, pentamer 
induced a specific dephosphorylation, without changes in protein expression, of key G1-
modulatory proteins, such as Cdc2, forkhead transcription factor and p53, although expression 
and phosphorylation of retinoblastoma protein decreased after pentamer treatment (Ramljak et 
al., 2005). These results showed that breast cancer cells are selectively susceptible to the 
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cytotoxic effects of pentameric procyanidin, and suggested the inhibition of cellular 
proliferation. Accordingly, a natural and synthetic pentameric EC-derived procyanidin inhibited 
the growth of breast cancer MDA MB 231 cells through the induction of cell cycle arrest in 
G0/G1 phase, the subsequent cell death being more likely necrotic rather than apoptotic 
(Kozikowski et al., 2003). Similarly, procyanidin-enriched extracts from cocoa caused growth 
inhibition with a blockade of the cell cycle at G2/M phase in human colonic Caco-2 cells 
(Carnésecchi et al., 2002), and EC induced S phase arrest in the cell cycle progression in LoVo 
colon cancer cells (Tan et al., 2000). Flavanol dimers B1-B4 decreased growth of the androgen-
sensitive (LnCaP) and androgen-resistant (DU145) human prostate cancer cell lines, and PB2, 
oleylated or not, displaced testosterone from membrane androgen receptors and induced DU145 
tumor xenograft regression (Kampa et al., 2011). In addition, procyanidin B3 inhibited 
acetylation-dependent prostate cell proliferation and expression of cell-cycle control genes 
(cyclin E and D1), subsequently increasing cell death in LNCaP cell line (Choi et al., 2011). 
EC seemed to be inactive to induce growth suppression, apoptosis induction, ROS formation 
and mitochondrial depolarization in the metastatic human prostate cancer DU145 cells (Chung 
et al., 2001, Ravindranath, M.H. et al., 2006), but it reduced proliferation of the poorly 
differentiated HH639 epithelial ovarian cancer cells (Ravindranath et al., 2006). 
2.3.2.- Apoptosis 
Apoptosis induction may be considered one of the important targets in a preventive approach 
against cancer. This programmed-cell death is a complex process that involves the active 
participation of affected cells in a self-destruction cascade and is defined by a set of 
characteristic morphological features such as membrane blebbing, shrinkage of the cell and 
nuclear volume, chromatin condensation and nuclear DNA fragmentation due to endonuclease 
activation (Ramos, 2007, Ramos, 2008). At the molecular level, apoptosis shows characteristic 
biochemical hallmarks, and two effector mechanisms: (a) extrinsic, mediated by death receptors 
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CD95/Fas/ Apo1, TNF receptor 1, TNF receptor 2, and death receptors 3 to 6, and (b) intrinsic 
(mitochondria-mediated) (Ramos, 2007). In the mitochondria, propagation of the apoptotic 
signal is regulated by proteins such as Bcl-2 family members (Bcl-2, Bcl-xL, and Bcl-w), which 
exert anti-apoptotic effects, and Bid, Bad, Bak, Bax, and Bim, which exert pro-apoptotic effects 
(Ramos, 2007). Both cascades converge in a common executor mechanism involving DNA 
endonucleases, which cleave regulatory and structural molecules and activated proteases 
(caspases) and lead to the cellular death (Table 4) (Ramos, 2007, Ramos, 2008). 
Procyanidin induced apoptosis in prostate cancer PC-3 cells by altering the mitochondrial 
membrane potential, but when the incubation time was extended the necrotic rate was higher 
than that of the apoptosis (Shang et al., 2009). Accordingly, procyanidin B2 decreased 
expression of the NF-ĸB-regulated anti-apoptotic proteins such as Bcl-xL, Bcl-2, X-linked 
inhibitor of apoptosis protein and cellular FLICE-inhibitory protein (cFLIP), leading to a 
decreased cell viability, although it did not significantly affect the progression of the cell cycle, 
or parameters of apoptosis in Hodgkin´s lymphoma cells (KM-H2, L-428, L-540 and L-1236 
cells) (Mackenzie et al., 2008). Importantly, PB2 did not affect cell viability of Daudi B 
lymphoblast cells and Jurkat T leukemia cells, both lacking constitutive NF-ĸB activation. This 
suggests the involvement of B2-mediated NF-ĸB inhibition in Hodgkin´s lymphoma cell 
survival and the low toxicity of this procyanidin to other cells (Mackenzie et al., 2008). In 
neurons and fibroblasts treated with H2O2, EC glucuronide did not affect the peroxide-increased 
caspase-3 activity, whilst EC and 3´-O-methyl EC reduced the peroxide-induced caspase-3 
activation (Spencer et al., 2001a, Spencer et al., 2001b). In this line, the protection elicited by 
3´-O-methyl EC was not different from that of EC, suggesting that the hydrogen-donating 
antioxidant activity is not the primary mechanism of protection (Spencer et al., 2001b). 
Similarly, phenolic-rich extracts of both unroasted and roasted cocoa prevented the 
programmed cell death induced by celecoxib in MLP29 liver cells, i.e.: diminished the number 
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of cells in the sub-G1 peak and the activation of Bax, partially restored the levels of Bcl-2, and 
decreased the released cytochrome c in the cytosol and the activation of caspase 3 (Arlorio et 
al., 2009). Moreover, the protective effect of cocoa against liver cytotoxicity provoked by 
celecoxib was probably attributable to induction of the autophagic process, as shown by 
enhanced Beclin 1 expression and accumulation of monodansylcadaverine in autolysosomes, 
suggesting that apoptosis was prevented by stimulating autophagy (Arlorio et al., 2009). 
Hexameric procyanidins also delayed the DOC-induced Caco-2 cell apoptosis (Da Silva et al., 
2012). 
Interestingly, a synergistic effect has been reported to induce apoptosis by combination of drugs 
and/or natural compounds and cocoa phenols (Ramos, 2007). In this line, EC showed a major 
synergistic effect on the induction of apoptosis in gastric cancer MKN-45 cells treated with 
epigallocatechin-3-gallate (Horie et al., 2005) and in human lung cancer PC-9 cells (Suganuma 
et al., 1999). Similarly, the combination of curcumin with EC increased the inhibition of cell 
growth as compared to curcumin or EC alone, as well as the apoptosis rate and the expression 
of related genes to the programmed cell death such as GADD153 and GADD45 in PC-9 cells 
(Saha et al., 2010). 
2.3.3.- Proliferation/survival 
The most important signaling pathways regulating cell proliferation and survival involve 
PI3K/AKT, growth factor receptors/Ras/MAPKs, and NF-κB, which also importantly 
contributes to the inflammatory process, as mentioned above (Table 5) (Ramos, 2008). 
Cocoa phenolic compounds can interact with signaling proteins and modulate their activity. A 
cocoa extract and EC exerted a neuroprotective effect by down-regulating proteins involved in 
apoptosis such as p38 and phosphorylated JNK (Ramiro-Puig et al., 2009). Moreover, a cocoa 
procyanidin fraction and PB2 inhibited TPA-induced neoplastic transformation of JB6 P+ 
mouse epidermal cells, COX-2 expression, phosphorylation of MEK and p90 ribosomal s6 
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kinase and attenuated activator protein-1 (AP1) and NF-ĸB stimulations (Kang et al., 2008). In 
this study, it was demonstrated that the cocoa procyanidin fraction and PB2 inhibited the kinase 
activity of MEK1 and directly bound with MEK1. PB2 and a cocoa polyphenolic extract also 
protected colonic Caco-2 cells against acrylamide-induced cytotoxicity by blocking the 
activation of the apoptotic pathway as prevented the increase in the levels of p-JNK induced by 
the toxicant, whereas ERK seemed to play an indirect protective role through the promotion of 
cell proliferation and survival signaling (Rodriguez-Ramiro et al., 2011b). Similarly, hexameric 
procyanidins prevented oncogenic events initiated by DOC through the interaction with Caco-2 
cell membranes, and inhibited the DOC-promoted activation of AKT, ERK and p38, as well as 
the downstream transcription factor AP-1 (Da Silva et al., 2012). In monocytes, PB2 dimer 
decreased the endotoxin-induced expression of COX-2, through the inhibition of MAPKs (p38, 
JNK, and ERK) and NF-κB (Zhang, et al., 2006). However, PB2 and EC did not have an 
obvious effect on Caco-2 and SW480 colon carcinoma cells, whereas PB2 promoted cell 
growth in SW480 cells by increasing p-AKT and p-ERK levels (Ramos et al., 2011). This 
different response depends on the distinct chemical structure of the compound and the different 
degree of cell differentiation: it ranges from no effect of any of the flavanols on Caco-2 cells to 
a survival/proliferative effect of PB2 on SW480 cell line. This highlights the importance of an 
holistic approach to the study of the biological effects of phytochemicals and calls for caution 
on the conclusions derived from their studies (Ramos et al., 2011). In addition, it has been 
suggested that the capacity of procyanidins to interact with the cell membrane and to prevent 
those cell membrane-associated events can in part explain their effects (Da Silva et al., 2012). 
EC had no prominent effects on the HepG2 cell rate (Ramos et al., 2005), it did not induce the 
caspase cascade for apoptosis or affect the expression of pro-apoptotic Bcl-2 proteins, such as 
Bax or Bcl-x, but induced a sustained activation of the major survival signals (Granado-Serrano 
et al., 2007). In this regard, EC induced a time-dependent regulation of survival/proliferation 
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pathways in HepG2 cells (Granado-Serrano et al., 2009). EC-induced cell survival was a rapid 
event that was accompanied by early and sustained activation of AKT and ERK, as well as 
protein kinase C (PKC)-α, in concert with unaltered JNK levels and early inactivation of key 
death-related signals like PKC-δ. All these suggest that EC induces cellular survival through a 
tight regulation of survival/proliferation pathways that required the integration of different 
signals and persists over time (Granado-Serrano et al., 2009).  
 
2.4.- Effects on angiogenesis and metastasis 
Angiogenesis, the formation and growth of new blood vessels from preexisting 
microvasculature (Ramos, 2008), is a key stage in tumor growth, invasion, and metastasis 
(Table 6). 
Cocoa polyphenols inhibited TNFα-induced up-regulation of vascular endothelial growth factor 
(VEGF) by reducing TNFα-induced activation of the nuclear transcription factors AP-1 and 
NF-ĸB, which are key regulators of VEGF expression (Kim et al., 2010). Similarly, (+)-
catechin inhibited tumour-specific angiogenesis by regulating the production of pro- and anti-
angiogenic factors such as pro-inflammatory cytokines, nitric oxide, VEGF, IL-2 and tissue 
inhibitor of metalloproteinase-1 (Guruvayoorappan and Kuttan, 2008). In addition, in (+)-
catechin-treated animals the TNFα production, the proliferation, migration and tube formation 
of endothelial cells as well as the microvessel outgrowth in the rat aortic ring assay were 
inhibited (Guruvayoorappan and Kuttan, 2008). Accordingly, it has been reported that the 
chemical modification of EC by its acylation improved the anti-cancer and anti-angiogenic 
activities of this flavanol (Matsubara et al., 2007). EC conjugated with fatty acid (acyl-catechin) 
strongly inhibited DNA polymerase activity, HL-60 cell growth and angiogenesis. EC 
conjugated with palmitic acid ((2R,3R)-3′,4′,5,7-tetrahydroxyflavan-3-yl hexadecanoate, 
epicatechin-C16) was the strongest inhibitor in DNA polymerase α, β, λ and angiogenesis 
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assays. Epicatechin-C16 also suppressed human endothelial cell (HUVEC) tube formation on 
reconstituted basement membrane, suggesting that it affected not only DNA polymerase 
activity but also the signal transduction pathways needed for the tube formation in HUVECs 
(Matsubara et al., 2007). 
Metastasis involves the interplay of extracellular matrix degradation, proteolysis, cell adhesion, 
cell migration, angiogenesis, and invasion. Dietary polyphenols have also been reported to 
interfere with cancer cell adhesion and movement processes through multiple mechanisms 
(Ramos, 2008). Inhibition of gap-junction intercellular communication is strongly related to 
tumorigenesis (Ramos, 2008). Cocoa polyphenol extracts dose-dependently attenuated H2O2-
induced inhibition of gap-junction intercellular communication in rat liver epithelial cells (Lee 
et al., 2010). Cocoa polyphenol extracts also inhibited the H2O2-induced phosphorylation and 
internalization of connexin 43, the accumulation of ROS and activation of ERK through the 
direct binding to MEK1, to inhibit its activity (Lee et al., 2010). Importantly, EC arrested 
growth of murine mammary 4T1 cancer cells, decreased ROS generation, downregulated 
metalloprotease-9 and inhibited invasion of tumor cells into embryonic stem cell-derived and 
into vascularized tissues (Günther et al., 2007). 
 
3.- Studies in animal models 
Animal studies offer a unique opportunity to assess the contribution of the physiological effects 
of consumption of cocoa and cocoa components in different models of carcinogenesis.  
Before considering application of a compound or product for prevention of cancer, 
toxicological and safety issues also have to be considered. Hence, no evidence of 
carcinogenicity was found in a chronic study of dietary doses as high as 5% of cocoa powder in 
rats (Tarka et al., 1991). On the contrary, extracts of cocoa have been shown to decrease the 
mutagenicity of carcinogens assayed by different tests. Cocoa liquor polyphenols showed an 
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inhibition of the mutagenic effect of the heterocyclic amines in the Ames test (Yamagishi et al., 
2000, Yamagishi et al., 2002). Likewise, in the micronucleus test in mice, cocoa liquor 
polyphenols administered orally reduced the occurrence of micronucleated cells after the 
injection of the potent DNA crosslinker mitomycin C (Yamagishi et al., 2001). 
Although current data are limited, cancer prevention by cocoa and its major components has 
been studied in different animal models for genetic and chemically-induced cancer, including 
mammary, pancreatic, lung, thyroid, prostate, leukemia, hepatic and colorectal cancers. Most of 
these studies have been conducted with cocoa polyphenol extracts or with pure compounds, 
whereas two of them have been conducted with a cocoa enriched diet (Table 7). The 
mechanisms involved in this protective effect of cocoa and its flavonoids appear at different 
stages of the carcinogenesis process, both in phases of tumor initiation and promotion and in 
tumor progress and metastasis. The following is a review of studies on the individual cancer 
types (Table 7). 
 
3.1.- Mammary and pancreatic cancers 
Cacao liquor is a major ingredient of chocolate and cocoa that is abundant in polyphenols, 
including catechins and their oligomers B-type proanthocyanidins (Natsume et al., 2000). 
Cacao liquor proanthocyanidins (CLPr) exerted inhibitory effects on the mutagenicity induced 
by diverse heterocyclic amines such as 1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP) 
(Yamagishi et al., 2000, Yamagishi et al., 2002). Yamagishi et al. (2002) investigated the 
potential protective effect of CLPr on PhIP-induced mammary and pancreas carcinogenesis in 
female Sprague–Dawley rats. CLPr were incorporated into the basal diet at doses of 0.025% or 
0.25% during the initiation or the post-initiation period of PhIP-induced carcinogenesis. They 
found that the incidences of pre-neoplastic lesions in the exocrine pancreas were dose-
dependently decreased by CLPr given during the initiation period, although the multiplicities in 
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each group were not significantly different. On the other hand, the incidences, multiplicities, 
and volumes of fibroadenomas or adenocarcinomas in mammary tumors showed a tendency to 
decrease at the dose of 0.25% CLPr (post-initiation) although without statistical significance. 
This different organ effect might be due to dissimilar concentrations of CLPr in the target 
tissues. Altogether, CLPr diet administered during the initiation period of PhIP-induced 
carcinogenesis was able to inhibit the initiation stage of pancreatic but not mammary 
carcinogenesis. Irrespective of the mechanisms involved, oxidative stress is implicated in the 
initiation phases of carcinogenesis (Reuter et al., 2010); therefore, due to the amount of 
antioxidant flavonoids in CLPr (Natsume et al., 2000), their administration during the initiation 
period seems to provoke an inhibitory effect against oxidative stress associated with the 
initiation stage of carcinogenesis. 
 
3.2.- Lung and thyroid cancers 
CLPr administered in the post-initiation period was also effective in suppressing lung and 
thyroid carcinogenesis (Yamagishi et al., 2003). In this study, the inhibitory effect of CLPr 
against tumorigenesis was examined in F344 male rats using a multi-organ initiation model. 
The multi-organ carcinogenesis model using diethylnitrosamine (DEN), N-methylnitrosourea 
(MNU), N-butyl-N-(4-hydroxybutyl)nitrosamine, dimethylhydrazine and 2,2’-dihydroxy-di-n-
propylnitrosamine as initiators (DMBDD treatment) is a useful tool for screening 
chemopreventive as well as tumorigenic activities of chemicals (Ito et al., 1996). CLPr was 
incorporated into the basal diet at a dose of 0.025% or 0.25%, starting 1 week after the final 
carcinogen treatment. At the end of the experimental period (36 weeks), significant reduction of 
adenocarcinoma development in the lungs and a tendency for a decrease in thyroid lesions were 
found, without any adverse effects in any major organ. Furthermore, the fact that CLPr 
decreased the development of carcinomas in the lung but not that of hyperplasias and adenomas 
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suggested some influence on progression from adenoma to carcinoma. Interestingly, the 
DMBDD group treated with the highest dose of CLPr further exhibited a higher survival rate 
than the DMBDD alone group. This effect seems to be the consequence of a delay in tumor 
development in the CLPr group, as evidenced by a significantly lower incidence of lung tumors, 
and albeit non-significant, lower incidences of pituitary, Zymbal’s gland and urinary bladder 
tumors, kidney nephroblastomas and angiosarcomas. 
 
3.3.- Prostate cancer 
The effects of cocoa polyphenols have also been studied against experimental prostate 
carcinogenesis in male Wistar–Unilever rats (Bisson et al., 2008). In this study, a polyphenolic 
extract obtained from a polyphenolic-enriched cocoa powder (Acticoa powder –AP-) was used. 
AP is a cocoa that contains a high percentage of flavanols preserved thanks to a patented 
process developed by Barry Callebaut (Louviers, France). The polyphenolic-enriched cocoa 
extract was given orally at doses of 24 and 48 mg/kg body weight starting two weeks before 
induction of prostate carcinogenesis and throughout the experiment (36 weeks). The induction 
of prostate tumors was performed using the direct acting chemical carcinogen MNU followed 
by chronic androgen stimulation with testosterone (Boileau et al., 2003). The administration of 
24 mg/kg of AP extract before the initiation and the promotion phases of cancer induction 
significantly reduced the incidence of prostate lesions in rats. However, the number of 
preneoplastic and neoplastic lesions observed in rats given 48 mg/kg of AP extract was higher 
than the observed in the group treated with 24 mg/kg. The reasons for this result could be that a 
higher dose of cocoa rich-polyphenolic extract may involve a mechanism of regulation such as 
a negative feedback that might enhance the development of prostate tumors rather than 
inhibiting them. Finally, similar to what has been found with cocoa liquor procyanidins 
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(Yamagishi et al., 2003), the preventive treatment of rats with AP extract at the low dose of 24 
mg/kg was associated with greater longevity. 
 
3.4.- Leukemia 
One of the major cocoa constituent, EC, has also showed to possess anti-carcinogenic activity 
in vivo. Papiez et al. (2011) have recently demonstrated that EC exert genotoxic and necrotic 
effects in Brown Norway rat myeloid leukemia cells. These properties may have utility in 
anticancer therapy against acute myeloid leukemia. The Brown Norway rat myeloid leukemia 
model used in this work was developed after intravenous inoculation with 10
6
 splenic-derived 
leukemia cells in Brown Norway rats. EC was given by gavage at a dose of 40 mg/kg body 
weight for 22 consecutive days from the second day after inoculation. The results indicated that 
EC was able to induce selective necrotic cell death in leukemia bone marrow. Likewise, there 
was a tendency for an increase of early apoptotic cells. On the contrary, EC induced neither 
necrosis nor apoptosis of non-leukemia cells. Thus, it could be suggested that EC will be 
helpful by inducing death in cancerous cells which are resistant to apoptosis, while inducing no 
toxicity in healthy cells. 
 
3.5.- Hepatic cancer 
The first animal study on the chemopreventive effects of a cocoa diet was performed by 
Granado-Serrano et al. (2009). Male Wistar rats were treated with DEN, a potent hepatotoxic 
agent, to induce liver hepatocarcinogenesis (Köhle et al., 2008, Sivaramakrishnan et al., 2008, 
Sundaresan and Subramanian, 2008). The basal diet was supplemented with 16% powdered 
Natural Forastero cocoa. To test both the preventive and the potential therapeutic activity of the 
cocoa-rich diet, the dietary intervention started either before or after the induction of 
hepatotoxicity. At the end of the intervention period (6 weeks), it was observed that the cocoa 
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diet protected the liver against the oxidative damage induced by DEN through the modulation 
of the activities of several Phase I (GR, GPx and catalase) and Phase II (GST) enzymes. More 
interestingly, the protective effect of cocoa also involved the regulation of key proteins of cell 
signaling cascades, which play a main role in the promotion of carcinogenesis. In particular, 
cocoa exerted an anti-apoptotic effect in the liver of DEN-treated animals that was associated 
with the prevention of both JNK and caspase-3 activations. The cocoa-diet also prevented the 
DEN-induced increase of the survival/proliferation signal PI3K/AKT, which has been 
considered a critical factor in the aggressiveness of hepatocellular cancer and has been 
associated with poor prognosis in liver cancer (Parekh and Rao, 2007, Schimtz et al., 2007). In 
detail, cocoa diet completely counteracted the hepatic damage induced by DEN in both pre-and 
post-treated animals, as phase I and II enzymes showed comparable values to those of animals 
only fed with cocoa or to control rats, and JNK levels were similar to untreated animals 
(Granado-Serrano et al., 2009). In addition, caspase-3 activity was not modified in animals fed 
with cocoa before DEN injection when compared to control rats, whereas animals receiving 
cocoa after DEN injection showed values of caspase-3 activity in between the levels of 
untreated animals and rats only injected with DEN. Altogether, these effects indicated a 
potential attenuation of the post-necrotic proliferation induced by DEN and a reduction of the 
number of initiated cells. 
 
3.6.- Colon cancer 
Cocoa has a high concentration of polyphenols such as procyanidins that are poorly absorbed in 
the intestine where they may have an important antioxidant and anti-inflammatory local 
function; therefore, they could have a major role in the prevention of colorectal cancer onset 
and development. Accordingly, the potentially important role of cocoa and their phenolic 
compounds for colon cancer prevention was first demonstrated by Weyant et al. (2001). In this 
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study, a genetic model of multiple intestinal neoplasia, the C57BL/6J Min/+ (Min/+) mice, was 
used. Min/+ mice have one mutated allele of the adenomatous polyposis coli (Apc) gene and 
spontaneously develop multiple intestinal tumors (Su et al., 1992); therefore, it is considered a 
reasonable murine model of inherited (familial adenomatous polyposis) and sporadic colorectal 
cancer in humans. Using this model, the authors demonstrated that the cocoa flavonoid catechin 
added to a diet in concentrations of 0.1 and 1%, was able to diminish the formation of intestinal 
tumors by 75 and 71%, respectively. Further mechanistic studies linked this effect to (+)-
catechin-induced changes in integrin-mediated intestinal cell-survival signaling, including 
structural alteration of the actin cytoskeleton and decreased focal adhesion kinase (FAK) 
tyrosine phosphorylation. FAK has been implicated in the regulation of cell migration, one of 
the earliest changes in adenoma development (Mahmoud et al., 1999), suggesting that (+)-
catechin could prevent the progression of initiated enterocytes to the adenoma stage.  
More recently, the chemopreventive ability of a cocoa rich-diet on colon carcinogenesis has 
been studied in detail in male Wistar rats using the well-defined azoxymethane (AOM)-induced 
colon cancer model (Rodrıiguez-Ramiro et al., 2011). Administration of the colon-specific 
carcinogen AOM to rodents provokes the development of aberrant crypt foci, pre-neoplastic 
lesions in the colon that may progress into cancer later on (Pritchard and Grady, 2011). Animals 
were fed with a cocoa-enriched diet (12%) starting two weeks before the carcinogenic induction 
and throughout the experimental period (8 weeks). This study demonstrated that a cocoa-rich 
diet could prevent the early stage of chemically induced colorectal cancer in rats. Cocoa feeding 
significantly reduced AOM-induced colonic aberrant crypt foci formation and crypt 
multiplicity. At the molecular level, the chemopreventive effects elicited by cocoa were due at 
least in part to its anti-oxidative and anti-inflammatory properties. Indeed, cocoa feeding was 
able to prevent oxidative stress by reverting to control values the diminished levels of GSH and 
the activities of GPx, GR and GST provoked by the toxicant. The cocoa-rich diet also prevented 
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the subsequent increase in AKT and ERK phosphorylation induced by AOM and the decrease 
in the levels of the proliferative marker cyclin D1 as well as cell proliferation. In addition, 
cocoa polyphenols suppressed intestinal inflammation induced by AOM through the inhibition 
of NF-κB signaling and the downregulation of the pro-inflammatory enzyme expressions of 
COX-2 and iNOS (Rodrıiguez-Ramiro et al., 2012). Finally, cocoa was also able to induce 
apoptosis as another complementary mechanism of chemoprevention during the progression of 
carcinogenesis through the upregulation of Bax levels and the downregulation of Bcl-xL 
(Rodrıiguez-Ramiro et al., 2012). 
 
4.- Studies in humans 
Although animal studies have indicated cancer preventive activity of cocoa, extrapolation of the 
results to the human situation is difficult. Exposure of humans to low doses of endogenous or 
exogenous carcinogens and tumor promoters may occur constantly and life-long. Additionally, 
the response of humans to carcinogens and chemoprotective agents may be influenced by 
genetic polymorphisms, changes in DNA methylation and epigenomic events (Milner, 2006). 
Indeed, epidemiologic studies of cocoa intake and cancer risk are few, and those assessing 
mortality by cancer provide only weak support for a benefit of cocoa. Consequently, 
confirmation of cancer preventive efficacy in humans requires large and long-lasting controlled 
clinical trials. 
 
4.1.- Epidemiologic studies 
Substantial laboratory data suggest that flavonoid-rich food could help to prevent 
cardiovascular disease and cancer (Andújar et al., 2012). Since cocoa is one of the richest 
sources of flavonoids, populations with a diet rich in cocoa products should show a significant 
protection against these two pathologies. 
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Perhaps the most prominent case in support of the cancer preventive effect of cocoa in humans 
is the Kuna tribe in Panama. The Kuna living in the San Blas district of Panama drink a 
flavanol-rich cocoa as their main beverage, contributing more than 900 mg/day and thus 
probably have the most flavonoid-rich diet of any population (Bayard et al., 2007). Examination 
of death certificates to compare cause-specific death rates from year 2000 to 2004 in mainland 
Panama and the San Blas islands where Kuna live, indicated that the rate of cardiovascular 
disease, diabetes mellitus and cancer among island-dwelling Kuna was much lower than in 
mainland Panama. This comparatively lower risk among Kuna from two of the most common 
causes of morbidity and mortality possibly reflects a very high flavanol intake. However, there 
are many risk factors and an observational study cannot provide definitive evidence (Bayard et 
al., 2007).  
Also in support of the anticancer effect of cocoa is a case-control study carried out in Spain 
(Garcia-Closas et al., 1999). The authors reported an inverse relation between the incidence of 
gastric cancer and flavonoid consumption. Additionally, data from the Iowa Women’s Study, 
established an inverse epidemiological relation between catechin consumption and the 
incidence of rectal cancer in post-menopausal women (Arts et al., 2002). 
Nevertheless, some human studies have failed to show a beneficial impact of cocoa intake in 
the rate of cancer appearance. A French study showed no significant association between a high 
chocolate dietary pattern and any stage of colorectal disease ranging from polyps, to adenomas, 
and colorectal cancer (Rouillier et al., 2005). An adenoma study in North Carolina also failed to 
observe a significantly lower prevalence of adenomatous polyps and colorectal cancer with 
chocolate consumption (McKelvey et al., 2000). Panelli et al. (1989) examined changes in 
mortality from urinary bladder cancer in Italy during the years 1950-81 in relation to changes in 
smoking habits and in coffee, cocoa and tea consumption. The authors found an increase of 
mortality throughout this period that was related to occupational exposures and to high-tar-
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content tobacco smoking, but consumption of coffee, cocoa and tea did not seem to be related 
to the increase in bladder cancer risk in Italy.  
In the Zutphen study, a prospective cohort study of 806 men aged 65 to 84 years at baseline, 
catechin intake was not associated with epithelial cancer or lung cancer when the models were 
adjusted for confounders (Arts et al., 2001). In a clinical trial carried out in Greece with cases 
(820) and controls (1,548) no significant association was found between flavanol consumption 
and the incidence of breast cancer (Peterson et al., 2003). In addition, in a recent update 
including data from 1965 to 2011, the authors showed a lack of solid evidence supporting a 
prevention of oral cancer by flavonoid intake (Varoni et al., 2012). 
Finally, there are a number of human studies that have shown a negative effect of cocoa intake 
on cancer incidence. In a case-control study in Burgundy (France), chocolate was identified as a 
risk factor for colorectal cancer (Boutron-Ruault et al., 1999). A correlation study on the 
association of disease rates with the dietary practices in various geographical areas has 
suggested that exposure to cocoa during prenatal life or childhood may be associated to the risk 
of both hypospadias and testicular cancer in the offspring (Giannandrea, 2009). However, the 
association between male reproductive diseases and consumption of cocoa has been linked to 
reproductive toxicity of cocoa theobromine (EFSA, 2008, Wang et al., 1992). In any case, the 
overall association at least may serve to stimulate further epidemiological and experimental 
studies. 
 
4.2.- Intervention studies 
Research on the incidence of flavanol intake and cancer risk in human subjects has been mostly 
focused on green and black tea consumption (Yang et al., 2009). Cocoa flavanols, monomeric 
catechins and polymeric procyanidins, are similar to those in tea and they also decrease the 
adverse effects of ROS. However, they have different chemical structures and different 
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metabolic functions, therefore, antimutagenic and anticancer properties reported for tea 
phenolics could not be attributed to cocoa flavanols. There are properly no human intervention 
studies attempting to show a correlation between cocoa intake and cancer prevention, but a few 
human intervention trials indicate that cocoa favorably affects intermediary factors in cancer 
progression (Maskarinec, 2009). 
Chronic inflammation and oxidative stress are significant contributing factors to carcinogenesis. 
ROS can damage DNA and interfere with DNA repair, leading to mutations that favor 
uncontrolled cell growth and replication. Thus, the antioxidant activity of cocoa flavanols is of 
particular interest for its potential influence on the initiation stage of carcinogenesis. In this line, 
Spadafranca et al. (2010) have demonstrated that dark chocolate consumption significantly 
improved DNA resistance to oxidative stress. In this study healthy subjects were assigned to a 
daily intake of 45 g of dark chocolate or white chocolate for 14 days and oxidative damage to 
mononuclear blood cells DNA was reduced in the dark chocolate group 2 h after consumption; 
22 h later the effect disappeared. 
In vitro and ex vivo studies support an anti-inflammatory effect of cocoa flavanols, but these 
effects have not always been replicated in vivo (Selmi et al., 2008). Thus, cocoa consumption 
reduced NF-κB activation in peripheral blood mononuclear cells in healthy voluntaries 
(Vázquez-Agell et al., 2011), but biomarkers of inflammation, including IL-6, were unaffected 
in patients at high risk of cardiovascular disease consuming cocoa powder (Monagas et al., 
2009). Overall, an increasing number of human trials have assessed changes in markers of 
oxidative stress and inflammation with cocoa products (reviewed by Maskarinec, 2009). 
However, whether modification of any of these parameters will correlate with a lower incidence 
of appearance or development of specific cancers is highly debatable. 
 
5.- Conclusion 
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This review addresses the potential anti-carcinogenic mechanisms of action that have been so 
far identified for cocoa and its main phenolic compounds, as well as the feasibility that they 
could occur in vivo. In general terms, those cellular mechanisms include the modulation of the 
redox status and multiple key elements in signal transduction pathways related to cell 
proliferation, differentiation, apoptosis, inflammation, angiogenesis and metastasis. Studies 
performed in animals have demonstrated that cocoa and its main phenolic components can 
prevent and/or slow down the initiation-progression of different types of cancers such as cancer 
of prostate, liver, colon, leukemia, etc. In addition, several human intervention studies have 
reported some favorable changes in biomarkers assessing antioxidant status. However, caution 
is needed when attempting to extrapolate the in vitro observations to in vivo animal tumor 
models and, most importantly, to humans. Cocoa products deserve further investigations since 
the molecular mechanisms of action are not completely characterized and many features remain 
to be elucidated. Additionally, more extensive, well-controlled clinical trials are needed to fully 
evaluate the potential of cocoa in terms of optimal dose, route of administration and cancer 
targets. Overall, these studies suggest that the daily consumption of small amounts of flavanols 
and procyanidins from cocoa or chocolate, in conjunction with usual dietary intake of 
flavonoids from mixed food sources, could offer a natural therapeutic approach to improve 
individual health status including potential efficient cancer prevention with minimal toxicity. 
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Table 1.- Cocoa and cocoa polyphenols modulation of cellular antioxidant status and phase I and II enzymes
a
. 
 
Polyphenol Concentration System studied Effects Reference 
Cocoa 
 
 
5-30 µg/mL 
 
10 µg/mL 
0.05-50 µg/mL 
0.05-50 µg/mL 
 
0.25 μg/ mL 
 
SH-SY5Y 
(neuroblastoma) 
Caco-2 (colon) 
HepG2 (hepatoma) 
 
HepG2 (hepatoma) 
 
MCF-7, SKBR3 
(breast) 
↓ H2O2/Fe
2+
 induced ROS production 
 
↓ acrylamide-induced GSH depletion, ↓ ROS generation, ↑ γ-GCS, ↑ GST 
↓ t-BOOH-induced death, ↓ GSH depletion, ↓ MDA, ↓ ROS generation, ↓ 
GPx and GR activation 
↑ GPx and GR 
 
↑ CYP1A1 mRNA, protein and activity, ↑ binding to XRE 
 
Ramiro-Puig, et al., 2009 
 
Rodriguez-Ramiro, et al., 2011b 
Martin,  et al., 2008 
 
Martin,  et al., 2010a 
Oleaga, C. et al, 2012 
 
Polymers 
procyanidins
b 
0.1-100 µM (0.03-
29 μg/mL) 
2.5-60 µM (0.73-
17.4 μg/mL) 
2.5-20 µM (0.73-
5.81 μg/mL) 
Calf thymus DNA 
 
Caco-2 (colon) 
 
Caco-2 (colon) 
↓ UVC-induced 8-oxodG 
 
(hexamer) ↓ TNF-induced oxidation 
 
(hexamer) ↓ DOC-induced cytotoxicity, ↓ oxidant generation, ↓ NADPH 
oxidase, ↓ Ca2+ 
Ottaviani,  et al., 2002 
 
Erlejman,  et al., 2008 
 
Da Silva, et al., 2012; Erlejman,. et 
al., 2006 
Procyanidin B2 10 µM (5.79 
μg/mL) 
0.1-100 µM (0.06-
57.9 μg/mL) 
60 µM (34.71 
μg/mL) 
10-30 µM (5.79-
17.37 μg/mL) 
1-10 µM (0.6-5.79 
μg/mL) 
1-20 µM (0.6-11.57 
μg/mL) 
Caco-2 (colon) 
 
HUVEC (umbilical 
vein endothelial) 
Caco-2 (colon) 
 
Hl-60 (leukemia) 
 
Caco-2 (colon) 
 
Caco-2 (colon) 
↓ acrylamide-induced GSH depletion, ↓ ROS generation, ↑ γ-GCS, ↑ GST 
 
↓ NADPH oxidase 
 
↓ TNF-induced oxidant formation 
 
↑↓ H2O2-induced 8-oxodG formation, ↓ H2O2/Fe
2+-
induced DNA damage, 
↑ H2O2/Cu
2+ 
induced DNA damage 
↑ GPx, GST and GR, ↓ t-BOOH-induced ROS production and ↓ caspase 
activation 
↑ GST, ↑ Nrf2 translocation 
Rodriguez-Ramiro,  et al., 2011b 
 
Steffen,  et al., 2008 
 
Erlejman,  et al., 2008 
 
Sakano, et al., 2005 
 
Rodriguez-Ramiro,  et al., 2011ª 
 
Rodriguez-Ramiro,  et al., 2011b 
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Epicatechin 12.4-100 μM (3.6-
29 µg/mL) 
50-100 µM (14.5-29 
μg/mL) 
2.5-25 µM (0.73-
7.26 μg/mL) 
2.5-300 µM (0.73-
87 μg/mL) 
5-100 µM (1.45-29 
μg/mL) 
 
0.1-100 µM (0.029-
29 μg/mL) 
10-50 µM (2.9-14.5 
μg/mL) 
10-50 µM (2.9-14.5 
μg/mL) 
25-100 µM (7.26-29 
μg/mL) 
0.1-100 µM (0.029-
29 μg/mL) 
120 µM (34.8 
μg/mL) 
10 µM (2.9 μg/mL) 
0.1-0.3 μM (0.029-
0.087 μg/mL) 
SH-SY5Y 
(neuroblastoma) 
HepG2 (hepatoma) 
 
HepG2 (hepatoma) 
 
Calf thymus DNA 
 
HepG2 (hepatoma), 
PC12 
(pheochromocytoma) 
Calf thymus DNA 
 
HepG2 (hepatoma) 
 
HepG2 (hepatoma) 
 
MCF-7 (breast) 
 
HUVEC (umbilical 
vein endothelial) 
Caco-2 (colon) 
 
HepG2 (hepatoma) 
Astrocytes and 
neurons (primary 
culture) 
↓ H2O2/Fe
2+-
induced ROS production 
 
↓ t-BOOH-induced death, ↓ GSH depletion, ↓ ROS generation, ↑ GPx and 
GR 
↓ t-BOOH-induced lipid peroxidation, ↓ GSH and tocopherol depletion, ↑ 
GPx 
↓ Cu2+ induced radical formation 
 
↓ Pb2+ induced cell death, ↓ ROS formation, ↓ mitochondrial dysfunction, 
↑ Ca2+dysregulation, ↓ lipid oxidation, ↓ membrane fluidity 
 
↓ UVC-induced 8-oxodG 
 
↓ N-nitrosamine-induced DNA damage 
 
↓ heterocycle amine-induced DNA damage, ↓ CYP1A1 activity 
 
↑ NADPH cytochrome c reductase activity 
 
↓ NADPH-oxidase 
↓ TNF-induced oxidant formation 
 
↑ Nrf2 translocation 
↑ Nrf2, ↑ GSK 
Ramiro-Puig,  et al., 2009 
 
Martin,  et al., 2010b 
 
Murakami,  et al., 2002 
 
Azam, et al., 2004 
 
Chen,  et al., 2002 and 2003 
 
 
Ottaviani,  et al., 2002 
 
Delgado,  et al., 2009 
 
Haza . and Morales, 2011 
 
Rodgers,  and Grant,  1998 
Steffen, Y., 2007 and 2008 
Erlejman,  et al., 2008 
 
Granado-Serrano,  et al, 2010 
Bahia, et al., 2008 
3´O-methyl 
epicatechin 
1-30 µM (0.3-9.15 
μg/mL) 
 
Cortical neurons 
(primary culture), 
dermal fibroblasts 
↓ H2O2-induced cell death and caspase-3 activity 
 
 
Spencer,  et al., 2001b 
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1-30 µM (0.3-9.15 
μg/mL) 
0.1-100 µM (0.03-
30.5 μg/mL) 
FEK4 (skin 
fibroblasts) 
HUVEC (umbilical 
vein endothelial) 
↓ UVA-induced oxidative damage 
 
↓ NADPH-oxidase (= 4´-O-methyl EC and EC-glucuronide) 
Basu-Modak, et al., 2003 
 
Steffen, et al., 2008 
Catechin 0.1-100 µM (0.029-
29 μg/mL) 
10-50 µM (2.9-14.5 
μg/mL) 
10-50 µM (2.9-14.5 
μg/mL) 
120 µM (34.8 
μg/mL) 
100 µM (29 μg/mL) 
Calf thymus DNA 
 
HepG2 (hepatoma) 
 
HepG2 (hepatoma) 
 
Caco-2 (colon) 
 
Int-407 (intestine) 
↓ UVC-induced 8-oxodG 
 
↓ N-nitrosamine-induced DNA damage 
 
↓ heterocycle amine-induced DNA damage, ↓ heterocycle amine-induced 
CYP1A1 activity, ↑ UGT activity 
↓ TNF-induced oxidant formation 
 
↓ lipid peroxidation, ↓ ROS formation, ↑ GPx, ↑ GR, ↑ Nrf2, ↑ HO-1 
Ottaviani,  et al., 2002 
 
Delgado, et al., 2009 
 
Haza,  and Morales, 2011 
 
Erlejman,  et al., 2008 
 
Cheng, et al., 2012 
 
a
 The arrow indicates an increase (↑) or decrease (↓) in the levels or activity of the different analysed parameters. In certain cases, opposing results have been 
obtained since the studies were carried out in different cell types (non-tumorigenic, different cancer cell lines, etc.) and/or the final effects may depend on the 
dose and time of treatment with the phenolic compound. 
b
 Concentration in μg/mL was calculated as epicatechin equivalents. 
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Table 2.- Cocoa and cocoa polyphenols modulation of proteins involved in the inflammatory process
a
. 
 
Polyphenol Concentration System studied Effects Reference 
Cocoa 
 
 
50 µM GAE (14.5 
μg/mL) 
5-80 µg/mL 
0.1-10 µg/mL 
0.5-20 mg/L 
10 µg/mL 
Caco-2 (colon) 
 
ELY.BU.OU6 
(thymoma) 
Monocytes 
HL-60 (leukemia) 
Caco-2 (colon) 
↓ PGE2 
 
↓ MCP1, ↓ TNF-α, ↓ IL1α, ↓ IL6, ↓ LPS-induced TNF-α secretion, ↓ NO 
 
↓ PMA-induced superoxide production, ↓ IL1α, ↓ IL6 
↓ XO- and TPA-induced superoxide production 
↓ TNF-induced IL-8, COX-2, iNOS and NFκB activation 
Romier-Crouzet, et al., 2009 
 
Ramiro, et al., 2005 
 
Zeng, et al., 2011 
Lee, et al., 2006 
Rodriguez-Ramiro et al., 2012 
Polymers 
procyanidins 
2.5-60 µM (0.73-
17.4 μg/mL) 
Caco-2 (colon) (hexamer) ↓ TNF-induced NFκB activation and iNOS Erlejman, et al., 2008 
Procyanidin B2 1.7-50 µM (1-29 
μg/mL) 
50 µM (29 μg/mL) 
Jurkat T, H-RS, 
Daudi (Hodgkin 
lymphoma) 
Jurkat T 
(lymphocyte) 
↓ NFκB binding 
 
 
↓ TNF- and PMA-induced NFκB activation (=PB1) 
Mackenzie, et al., 2004, 2008 and 
2009 
 
Mackenzie, et al., 2009 
Epicatechin 200-400 µM (58-
116 μg/mL) 
1.7-8.6 μM 
(5-25 µg/mL) 
1-10000 µM 
(0.29-2900 μg/mL) 
1.7-17.2 µM 
(4.93-49 μg/mL) 
10 µM (2.9 μg/mL) 
ELY.BU.OU6 
(thymoma) 
Macrophages 
(primary culture) 
Aortic endothelial 
 
Jurkat T 
(lymphocyte) 
HepG2 (hepatoma) 
↓ MCP1, ↓ TNF-α, ↓ IL1α, ↓ IL6, ↓ NO 
 
↓ LPS-induced nitrite and TNFα production 
 
↓ LPS-induced nitrite and TNFα production 
 
↓ TNF-stimulated NFκB 
 
↑ NFκB 
Ramiro, et al., 2005 
 
Guruvayoorappan, and Kuttan, 2008 
Schroeder, et al., 2001 
 
Mackenzie, et al., 2004 and 2006 
 
Granado-Serrano, et al, 2010 
Catechin 1.7-8.6 μM 
(5-25 µg/mL) 
1-10000 µM 
(0.29-2900 μg/mL) 
Macrophages 
(primary culture) 
Aortic endothelial 
↓ LPS-induced nitrite and TNFα production 
 
↓ LPS-induced nitrite and TNFα production 
Guruvayoorappan, and Kuttan, 2008 
Schroeder, et al., 2001 
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a
 The arrow indicates an increase (↑) or decrease (↓) in the levels or activity of the different analysed parameters.  
b
 Concentration (μM) was in gallic acid equivalents (GAE). 
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Table 3.- Cocoa and cocoa polyphenols modulation on cell cycle
a
. 
 
Polyphenol Concentration System studied Effects Reference 
Polymers 
procyanidins 
0.25-5 µM (0.073-
1.45 μg/mL)b 
100 µg/mL 
 
 
25-100 µg/mL 
 
5-100 µg/mL 
0.1-100 nM (0.06-
57.9 ng/mL) 
25-100 µM (14.5-
57.9 μg/mL) 
Raji (lymphoma), 
HL-60 (leukemia) 
MDA-MB231, 
MB231, MDA-
MB468 (breast) 
MBA-MB 231 
(breast) 
Caco-2 (colon) 
LNCaP, DU145 
(prostate) 
LNCaP, PC-3 
(prostate) 
↓ Topo II (= B2, B5 and B2+B5) 
 
(pentamer) G0/G1 arrest, ↓ p-Cdc2, ↓ p-FOXO, ↓ p-p53, = pRb 
 
 
(synthethic pentamer) G0/G1 arrest 
 
G2/M arrest 
(dimers B1 and B4) ↓ cell growth 
 
(Procyanidin B3) ↓ cell growth, ↓ cyclin E, ↓ cyclin D1 
Lanoue, et al., 2009 
 
Ramljak, et al., 2005 
 
 
Kozikowski, et al., 2003 
 
Carnésecchi, et al., 2002 
Kampa, et al., 2001 
 
Choi, et al., 2011 
Procyanidin B2 0.1-100 nM (0.06-
57.9 ng/mL) 
LNCaP, DU145 
(prostate) 
↓ cell growth Kampa, et al., 2001 
Epicatechin 5-1000 µM (1.45-
290 μg/mL) 
50-100 µM (14.5-29 
μg/mL) 
LoVo (colon) 
 
DU145 (prostate), 
HH639 (ovary) 
S arrest 
 
= ↓ growth, apoptosis, mitochondrial depolarization 
Tan, et al., 2000 
 
Chung, et al, 2001, Ravindranath,et 
al., 2006 
 
a
 The arrow indicates an increase (↑) or decrease (↓) in the levels or activity of the different analysed parameters. In certain cases, opposing results have 
been obtained since the studies were carried out in different cell types and/or the final effects may depend on the dose and time of treatment with the 
phenolic compound. 
b
 Concentration in μg/mL was calculated as epicatechin equivalents. 
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Table 4.- Cocoa and cocoa polyphenols modulation of the apoptotic process
a
. 
 
Polyphenol Concentration System studied Effects Reference 
Cocoa 
 
0.5 mg/mL MLP29, AML12 
(liver) 
↓ celecoxib-induced sub-G1 peak, ↓ Bax, ↑ Bcl-2, ↓ cytochrome c release, 
↓ caspase-3 activity, ↑ Beclin-1 
Arlorio, et al., 2009 
Polymers 
procyanidins 
300 µg/mL 
2.5-20 µM
b
 (0.73-
5.8 μg/mL) 
PC-3 (prostate) 
Caco-2 (colon) 
↓ m 
(hexamer) ↓ DOC-induced apoptosis 
Shang, et al., 2009 
Da Silva, et al., 2012 
Procyanidin B2 2.5-50 µM (1.6-
28.92 μg/mL) 
Daudi, H-RS 
(lymphoma 
Hodgkin) 
↓ BclxL, ↓ Bcl-2, ↓ XIAP, ↓ cFLIP Mackenzie, et al., 2008 
Epicatechin 30 µM (8.7 μg/mL) 
 
50-300 µM (14.5-87 
μg/mL) 
(+ 100 µM, 45.84 
μg/mL) 
100-200 µM (29-58 
μg/mL) 
(+ 10-20 µM, 3.7-
7.4 μg/mL) 
FEK4 (skin 
fibroblasts) 
KATO-III, MKN-45 
(gastric) 
 
 
A549, PC-9 (lung) 
↓ H2O2
 
induced caspase-3 
 
(+ EGCG) ↑ apoptosis induction 
 
 
 
(+ curcumin) ↓ cell growth, ↑ apoptosis rate, ↑ GADD153, ↑ GADD45 
Spencer, et al., 2001b 
 
Horie, et al., 2005 
 
 
 
Saha, et al., 2010 
3´O-methyl 
epicatechin 
10-30 µM (3-9.15 
μg/mL) 
Cortical neurons 
(primary culture), 
dermal fibroblasts 
FEK4 (skin 
fibroblasts) 
↓ H2O2-induced caspase-3 activity Spencer, et al., 2001a and 2001b 
EC-glucuronide 10-30 µM (2.9-8.7 
μg/mL) 
Cortical neurons 
(primary culture) 
↓ H2O2-induced caspase-3 activity Spencer, et al., 2001a 
 
a
 The arrow indicates an increase (↑) or decrease (↓) in the levels or activity of the different analysed parameters. 
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b
 Concentration in μg/mL was calculated as epicatechin equivalents. 
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Table 5.- Cocoa and cocoa polyphenols modulation on cell survival/proliferation
a
. 
 
Polyphenol Concentration System studied Effects Reference 
Cocoa 
 
5-30 µg/mL 
 
0.05-50 µg/mL 
10 µg/mL 
SH-SY5Y 
(neuroblastoma) 
HepG2 (hepatoma) 
Caco-2 (colon) 
↓ p38, ↓ JNK 
 
↑ ERK 
↓ acrylamide-induced p-JNK 
Ramiro-Puig, et al., 2009 
 
Martin, et al., 2010a 
Rodriguez-Ramiro, t al., 2011b 
Polymers 
procyanidins
b
 
17-138 μM 
(5-40 µg/mL) 
2.5-20 µM (0.73-
5.81 μg/mL) 
JB6P+ (epidermal) 
 
Caco-2 (colon) 
↓ TPA-induced neoplastic transformation, ↓ COX-2, ↓ p-MEK, ↓ p90s6 
kinase, ↓ AP-1, ↓ NFκB 
(hexamer) ↓ DOC-induced AKT, ERK, p38 and AP-1 
Kang, et al., 2008 
 
Da Silva, et al., 2012 
Procyanidin B2 8.6-69 μM 
(5-40 µg/mL) 
10 µM (5.79 
μg/mL) 
10 µM (5.79 
μg/mL) 
10-100 µM (5.79-
57.9 μg/mL) 
10-50 µM (5.79-
28.93 μg/mL) 
JB6P+ (epidermal) 
 
Caco-2 (colon) 
 
Caco-2 (colon) 
 
THP-1 (monocytes) 
 
SW480 (colon) 
↓ TPA-induced neoplastic transformation, ↓ COX-2, ↓ p-MEK, ↓ p90s6 
kinase, ↓ AP-1, ↓ NFκB 
↓ acrylamide-induced p-JNK 
 
↑ ERK, ↑ p38 
 
↓ endotoxin-induced COX-2, ↓ p38, ↓ JNK, ↓ ERK, ↓ NFκB 
 
= ↑ proliferation, = ↑ p-AKT, = ↑ p-ERK 
Kang, et al., 2008 
 
Rodriguez-Ramiro, et al., 2011b 
 
Rodriguez-Ramiro, et al., 2011ª 
 
Zhang, et al., 2006 
 
Ramos, et al., 2011 
Epicatechin 12-100 μM 
(3.6-29 µg/mL) 
10-50 µM (2.9-14.5 
μg/mL) 
1-1000 µM (0.29-
290.5 μg/mL) 
SH-SY5Y 
(neuroblastoma) 
Caco-2, SW480 
(colon) 
HepG2 (hepatoma) 
↓ p38, ↓ JNK 
 
= proliferation, = p-AKT, = p-ERK 
 
= Bax, = Bclx, ↑ p-AKT, ↑ p-ERK, ↑ PKCα, = JNK, ↓ PKCδ 
Ramiro-Puig, et al., 2009 
 
Ramos, et al., 2011 
 
Ramos, et al., 2005, Granado-
Serrano et al., 2007 and 2010 
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a
 The arrows indicate an increase (↑) or decrease (↓) in the levels or activity of the different analysed parameters. In certain cases, opposing results have been 
obtained since the studies were carried out in different cell types (non-tumorigenic, different cancer cell lines, etc.) and/or the final effects may depend on the 
dose and time of treatment with the phenolic compound. 
b
 Concentration in μg/mL was calculated as epicatechin equivalents. 
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Table 6.- Cocoa and cocoa polyphenols modulation on angiogenesis and metastasis
a
. 
 
Polyphenol Concentration System studied Effects Reference 
Cocoa 
 
 
5-40 µg/mL 
10-100 µg/mL 
JB6P+ (epidermal) 
RLE (liver) 
↓ TNF-induced VEGF, ↓ AP-1, ↓ NFκB 
↓ H2O2-induced inhibition of gap-junction phosphorylation and 
internalization of connexion 43, ↓ ROS generation, ↓ ERK, ↓ MEK1, = 
p38 
Kim, et al., 2010 
Lee, et al., 2010 
Epicatechin 1-100 µM (0.29-29 
μg/mL) 
10 µM (2.9 μg/mL) 
HL-60 (leukemia) 
 
CGR8 (embryonic 
stem cells) 
(EC-acylated and EC-C16) ↓ DNA polymerase and angiogenesis 
 
↓ growth, ↓ ROS generation, ↓ MMP-9, ↓ angiogenesis 
Matsubara, et al., 2007 
 
Günther, et al., 2007 
Catechin 17-86 μM 
(5-25 µg/mL) 
B16F.10 (melanoma) ↓ NO, ↓ VEGF, ↓ IL2, ↓ TIMP-1, ↓ TNF production, ↓ pro-inflammatory 
cytokines 
Guruvayoorappan, and Kuttan,, 
2008 
 
a
 The arrow indicates an increase (↑) or decrease (↓) in the levels or activity of the different analysed parameters. 
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Table 7.- Summary of cancer preventive effects of cocoa and cocoa flavonoids in animal models  
 
 
 
Cancer 
type 
 
Model (carcinogen) 
 
 
Intervention dose 
 
Duration
a
 
 
Main outcomes
b
 
 
Reference 
 
Mammary 
Pancreatic  
 
Lung 
Thyroid  
 
Prostate  
 
 
Leukaemia 
 
 
Hepatic  
 
 
Colon  
 
 
Colon  
 
Female Sprague-Dawley 
rats (PhIP) 
 
Male F344 (DMBDD) 
 
 
Male Wistar-Unilever 
rats (MNU+ TP) 
 
Brown Norway rat 
(leukaemia cells) 
 
Male Wistar rats (DEN) 
 
 
Female C57BL/6J-Min/1 
mouse 
 
Male Wistar (AOM).  
 
 
Procianidims of cocoa liquor  
(0.025% or 0.25%) 
 
Procianidims of cocoa liquor  
(0.025% or 0.25%) 
 
Cocoa rich-polyphenolic extract 
(24 or 48 mg/kg body weight) 
 
(−)-Epicatechin (40 mg/kg body 
weight) 
 
Cocoa rich-diet (16%) 
 
 
(+)-Catechin (0,1% or 1%) 
 
 
Cocoa-rich diet (12%) 
 
48w (d) or (p) 
 
 
36w (p) 
 
 
36w (b-d-p) 
 
 
3w (p) 
 
 
6w (b-d-p) or (p) 
 
 
10w  
 
 
8 w (b-d-p) 
 
 
 
↓ Incidence and multiplicity of 
pancreatic lesions  
 
↓ Incidence and multiplicity of 
carcinomas in lung and thyroid  
 
↓ Incidence of prostate tumours 
at 24 mg/kg body weight. 
 
↑ Necrosis of leukaemia bone 
marrow cells  
 
↓ Post-necrotic proliferation and 
reduced initiated cells. 
 
↓ Intestinal tumour number  
 
 
↓ pre-neoplastic lesions (aberrant 
crypt foci) 
 
 
Yamagishi, M. et al., 2002 
 
 
Yamagishi, M. et al., 2003 
 
 
Bisson, J.F. et al., 2008 
 
 
Papiez, M. et al., 2011 
 
 
Granado-Serrano, A.B. et 
al., 2009 
 
Weyant, M.J. et al., 2001 
 
 
Rodriguez-Ramiro, I. et al., 
2012 
 
a
w, weeks; dietary intervention before (b), during (d), post (p) carcinogen treatment. 
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b
 The arrow indicate an increase (↑) or decrease (↓). 
 
 
 
